Aydin Huseynov analyst LADENBURG

Currently out of the existing stock ratings of Aydin Huseynov, 45 are a BUY (83.33%), 9 are a HOLD (16.67%).

Aydin Huseynov

Work Performance Price Targets & Ratings Chart

Analyst Aydin Huseynov, currently employed at LADENBURG, carries an average stock price target met ratio of 18.14% that have a potential upside of 30.61% achieved within 58 days.

Aydin Huseynov’s has documented 94 price targets and ratings displayed on 18 stocks. The coverage is on the Healthcare sector.

Most recent stock forecast was given on CRVS, Corvus Pharmaceuticals at 16-Sep-2024.

Wall Street Analyst Aydin Huseynov

Analyst best performing recommendations are on TPST (TEMPEST THERAPEUTICS).
The best stock recommendation documented was for INO (INOVIO PHARMACEUTICALS) at 1/8/2021. The price target of $15 was fulfilled within 24 days with a profit of $5.78 (62.69%) receiving and performance score of 26.12.

Average potential price target upside

CALA Calithera Biosciences INCY yte INO Inovio Pharmaceuticals NKTR Nektar Therapeutics REGN Regeneron Pharmaceuticals SLS Sellas Life Sciences Group SPRB Spruce Biosciences  VYGR Voyager Therapeutics NXTC NextCure  ALLR Allarity Therapeutics ATHE Alterity Therapeutics Ltd CMPX Compass Therapeutics . PCSA Processa Pharmaceuticals TRIL Trillium Therapeutics PALI Palisade Bio CRVS Corvus Pharmaceuticals CGTX Cognition Therapeutics TPST Tempest Therapeutics

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Hold

$2

$1.97 (6566.67%)

$2

2 years 8 days ago
(15-Nov-2022)

3/4 (75%)

$-0.38 (-15.97%)

53

Buy

$8

$7.97 (26566.67%)

2 years 2 months 25 days ago
(29-Aug-2022)

0/1 (0%)

$4.17 (108.88%)

Buy

$140

$139.97 (466566.66%)

4 years 6 months 12 days ago
(11-May-2020)

0/2 (0%)

$3.2 (2.34%)

Buy

$340

$339.95 (679900.00%)

$240

7 years 7 months 26 days ago
(29-Mar-2017)

3/3 (100%)

$110.33 (71.65%)

163

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

Which stock is Aydin Huseynov is most bullish on?

Potential upside of $12.05 has been obtained for CRVS (CORVUS PHARMACEUTICALS)

Which stock is Aydin Huseynov is most reserved on?

Potential downside of $3.51 has been obtained for CMPX (COMPASS THERAPEUTICS .)

What Year was the first public recommendation made by Aydin Huseynov?

On 2020

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?